Some visit links earn us a commission.
Quick verdict
Found is the better pick for most patients on overall scoring. Found has the broadest medication catalog of any program here, spanning branded GLP-1s, compounded options and Lilly's newly approved oral pill, Foundayo (orforglipron). The 12-month commitment required for the lowest price is the catch.
That said, Embla wins on specific dimensions. Embla is the closest thing the US market has to a Noom-meets-Calibrate hybrid that actually leans into the medication. Heavy behavioral coaching, branded-first prescribing, structured 12-month curriculum. Best for buyers who want the program to do half the work.
Side-by-side
| Found | Embla | |
|---|---|---|
| Starts from | $169/mo (incl. medication) | $249/mo (+ med separate) |
| Monthly cost gap | Found is $80/mo cheaper than Embla | |
| Lock-in | 12-mo lock-in | 12-mo lock-in |
| Time to prescription | 5 days | 7 days |
| Consultation type | Asynchronous | Live |
| Affiliate network | Impact | Impact |
Score by dimension
Scores out of 10, equal-weighted across five dimensions. How we score. The winner of each dimension is highlighted.
| Found | Embla | |
|---|---|---|
| Pricing transparency | 6/10 | 4/10 |
| Cancellation terms | 3/10 | 7/10 |
| Onboarding experience | 8/10 | 6/10 |
| Medication options | 9/10 | 7/10 |
| Member reviews | 7.8/10 | 9.2/10 |
When to choose Found
Best for complex clinical workups
Patients whose obesity medicine clinician has flagged a non-standard medication path (multiple drug classes, off-label combinations or 503A-compounded options that other programs have exited).
Found wins on pricing transparency, onboarding experience, medication options and runs $80/mo cheaper than Embla at the entry tier ($169 vs $249). Over a year that's $960 you keep. The caveat: Patients new to GLP-1s who want a simple month-to-month commitment. The 12-month plan required for the lowest price is the most punitive structure short of WeightWatchers Clinic. Note also: Subject to ongoing Lilly compounded-tirzepatide enforcement risk
When to choose Embla
Best for structured behavior support
Patients who tried meds-only and bounced, and want a structured behavior program alongside GLP-1.
Embla wins on cancellation terms, member reviews on the dimensional scoring. The caveat: Buyers who only want the script and find coaching content patronizing.
If cost is your main filter
Found is the cheaper monthly: $169 all-in vs $249 for Embla. That's $80 a month or $960a year. The 12-month math matters most if you're planning to maintain on GLP-1 long-term. If you're running a 3-month trial, the $240 delta is small against the cost of stopping early on the wrong dose. Insurance changes the picture: if either program runs prior auth and your plan covers Wegovy or Zepbound, branded with copay can beat both cash-pay totals.
If lock-in is your main filter
Found (12-mo lock-in) and Embla (12-mo lock-in) sit at different cancellation tiers. Read both cancellation policies directly before signing; the on-page summary covers the headline but not the deletion-of-account or refund-window edge cases.
FAQ
Is Found cheaper than Embla?
Can I switch from Found to Embla mid-treatment?
Which program has better member feedback?
Read the full reviews
All head-to-head comparisons → · Full chart → · Cost guide · Programs guide
